Loading...

PODCAST

Moving Medicine Forward

CTI Clinical Trials

CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.

science life sciences

All Episodes

00:17:39

The Future is Cellular: Optieum Bio’s Next-Generation...

Moving Medicine Forward ·

2026/10/01

Glioblastoma remains one of the most aggressive and difficult-to-treat forms of brain cancer, with recurrence posing a significant challenge for patients and researchers alike. In this episode of Moving Medicine Forward, Jeremy Schrand sits down with Moya Daniels, Vice President, Head of Regulatory and QA at Optieum Biotechnologies, to discuss the company's novel CAR-T cell therapy program, OPTF01, and its potential to transform treatment for recurrent glioblastoma. Moya shares insights into the

en

00:17:34

One Mission, Many Journeys: Celebrating 27 Years of CTI

Moving Medicine Forward ·

2026/09/24

As CTI celebrates 27 years of moving medicine forward, Hadley Decker, Senior Director, Global Training and Development, and Natiq Fazlani, Research Associate, share their unique career journeys at CTI. Through the lens of two employees at very different stages of their careers, they discuss professional growth, the value of curiosity, and the culture that continues to shape CTI's mission of advancing clinical research and improving patients' lives. For more on the Research Associate Program

en

00:33:45

More Time, More Options, More Hope: The Alzheimer's...

Moving Medicine Forward ·

2026/09/17

Alzheimer's disease affects millions of individuals and families, yet many people remain unaware of the critical role early detection can play in improving outcomes. In this episode, host Jeremy Schrand is joined by Andrew Pytlik and Patti Hahn of the Alzheimer's Association to discuss the growing importance of cognitive screening, advances in diagnostic testing, and the steps individuals can take today to support long-term brain health. Together, they explore the realities facing patients,

en

00:22:38

Funding the Future: Closing Critical Gaps in...

Moving Medicine Forward ·

2026/09/10

Childhood cancer research faces unique challenges, from limited funding opportunities to fewer treatment options compared to adult cancers. In this episode of Moving Medicine Forward, host Jeremy Schrand is joined by Jill Brink, Executive Director of CancerFree KIDS, Dr. Meisam Nami of Cincinnati Children's, and Dr. Ezgi Elmas of CARTx Therapeutics to discuss how early-stage funding is helping researchers pursue bold ideas that could transform pediatric cancer care. Together, they explore the

en

00:22:59

MMF Rewind | Building Better Clinical Trials: Study...

Moving Medicine Forward ·

2026/09/02

This week, we're revisiting a previous conversation with Megan Kamm, Senior Vice President of Client Delivery, and Josh Schroeder, Vice President of Site & Field Operations, to discuss how strong planning, site partnerships, and cross-functional collaboration drive successful trial execution. From feasibility and study startup to patient-centered decision-making, biometrics strategy, and global expansion, they share insights into the operational challenges—and opportunities—behind bringing

en

00:33:44

Stronger Together: Families, Researchers, and...

Moving Medicine Forward ·

2026/08/27

Childhood cancer research advances through the combined efforts of families, researchers, advocates, and donors. In this episode, Matt Robinson of CancerFree KIDS and Dr. Lindy Miles of Cincinnati Children's discuss how early-stage research funding, clinical trials, and community support help bring new treatments to children with cancer. Matt shares his family's experience navigating leukemia treatment, while Dr. Miles offers insight into the scientific process behind developing the next

en

00:16:35

New Path, Same Purpose: Dedicated to Advancing...

Moving Medicine Forward ·

2026/08/20

After nearly 40 years caring for transplant patients and more than 25 years in clinical research, Dr. Helio Tedesco has made a unique transition from investigator to CRO medical leader. In this episode of Moving Medicine Forward, Dr. Tedesco reflects on the evolution of transplantation medicine, the challenges patients face before and after transplant, and why clinical research remains essential to improving long-term outcomes. He also shares how his experience conducting more than 25,000

en

00:22:30

Chill, Not Kill: How Quell Therapeutics is...

Moving Medicine Forward ·

2026/08/14

In this episode of Moving Medicine Forward, Jeremy Schrand is joined by Luke Devey, Chief Medical Officer at Quell Therapeutics, and Savannah Doliboa, Chief Commercial Officer at CTI, to discuss how engineered regulatory T cell therapies are being developed to “chill, not kill” the immune system. The conversation explores Quell Therapeutics’ approach to Treg cell therapy, the complexity of launching advanced cell therapy trials across Europe, and how strong collaboration helped accelerate study

en

00:20:30

Beyond the Fine Print: How Legal Affairs Enables...

Moving Medicine Forward ·

2026/08/05

Ian Hennessey, Vice President & General Counsel at CTI, joins Moving Medicine Forward to discuss the critical role legal affairs plays in advancing global clinical research. From navigating complex regulations and supporting trial operations to evaluating emerging technologies like AI, Ian shares how legal teams help organizations innovate responsibly while protecting patients and empowering scientific progress00:00 | Career Journey From healthcare law to clinical research. 02:41 | Leadership

en

00:17:11

Inside Pharmacovigilance: Detecting Risks, Protecting...

Moving Medicine Forward ·

2026/07/29

What happens behind the scenes to ensure new therapies are safe for patients? In this episode of Moving Medicine Forward, we are joined by John Kane, Vice President of Pharmacovigilance and Safety Services at CTI, to explore the critical role of drug safety throughout the clinical development process. John shares how safety teams collect and evaluate adverse event data, navigate complex global regulations, and help protect patients from clinical trials through post-market surveillance. He also

en

00:23:21

Building Better Clinical Trials: Study Start-Up,...

Moving Medicine Forward ·

2026/07/23

What does it take to set a complex global clinical trial up for success? In this episode of Moving Medicine Forward, we are joined by Megan Kamm, Senior Vice President of Client Delivery, and Josh Schroeder, Vice President of Site & Field Operations, to discuss how strong planning, site partnerships, and cross-functional collaboration drive successful trial execution. From feasibility and study startup to patient centered decision-making, biometrics strategy, and global expansion, they share

en

00:13:25

From Australia to China: CTI's APAC Growth Journey

Moving Medicine Forward ·

2026/07/15

Asia Pacific has become one of the fastest-growing regions in clinical research, offering sponsors new opportunities to advance clinical development in an increasingly complex global environment.In this episode, Pavels Anetko, Director of Clinical Operations and Clinical Project Management at CTI, shares insights from across the region, including Australia's strengths in early phase studies and CTI's recent expansion into China and Japan. 01:24 Pavels’ background, career journey, and

en

00:38:41

ALK Positive: How Patients are Driving Research

Moving Medicine Forward ·

2026/07/08

Summer Farmen and Jeff Sturm share their personal cancer journeys and the mission behind ALK Positive, CTI’s Q3 Charity of the Quarter.ALK Positive is a patient-driven organization dedicated to improving outcomes for individuals living with ALK-positive cancer.Together, they discuss how they became advocates within a global patient community, the importance of genetic testing and second opinions, and the role of research initiatives and clinical trials in advancing treatment options and improving

en

00:25:47

MMF Rewind | CTI's Next Chapter: A Conversation with...

Moving Medicine Forward ·

2026/07/01

This week, we're revisiting a previous conversation with Jon Koch, CEO, and Brian Lawrence, CFO and President, as they share their perspective on what’s next for CTI as the organization enters a new phase of growth. They reflect on CTI’s legacy of partnership and execution while outlining how they plan to expand its impact across complex clinical trials.From scaling capabilities and investing in talent to strengthening operational discipline and embracing data-driven decision-making, Jon and

en

00:14:41

Small Wins, Big Impact: Lessons from Pediatric Oncology

Moving Medicine Forward ·

2026/06/25

What does it take to design clinical trials that truly put patients first—especially when those patients are children?In this episode of Moving Medicine Forward, Dr. Radhika Peddinti, Medical Director at CTI, discusses her journey from pediatric hematology/oncology at the bedside to shaping clinical research at a global scale.Drawing on more than two decades of experience caring for children and their families, Dr. Pennant shares how those deeply human moments continue to influence how she

en

00:11:44

Biorepositories in Action: Protecting the Integrity...

Moving Medicine Forward ·

2026/06/17

In this episode, we’re joined by Rafael Miñana Prieto, Senior Manager of Operations for Laboratory Services at CTI, who oversees global biorepository operations across the U.S. and Europe. He walks through the full specimen lifecycle—from kit design and sample collection to storage, retrieval, and delivery—and explains why biological specimens are the foundation of clinical research. Rafael shares how consistent, end-to-end management, global standardization, and integrated laboratory services help

en

00:24:25

Engineering Organs: The Science Powering...

Moving Medicine Forward ·

2026/06/11

In this episode of Moving Medicine Forward, Dr. Robert Fisher—one of the pioneers of modern transplant surgery—explores the rapidly advancing field of xenotransplantation and why it may represent a true turning point in medicine.From CRISPR-driven genetic engineering to breakthroughs in immunosuppression and scalable organ production, Dr. Fisher breaks down how decades of research are converging to make cross-species organ transplants a clinical reality.The conversation also dives into what this

en

00:28:23

Adapting to Industry Rebound: The Next Phase of...

Moving Medicine Forward ·

2026/06/03

What does a recovering clinical research market actually look like in 2026?In this episode, Joel White, Owner of Market Cap Consulting, and Ryan Gifford, Vice President, Global Laboratory Services, Business Development & Client Management at CTI, join us to unpack the state of the industry—from the rebound in biotech funding to the growing importance of execution, site relationships, and smarter trial design.We explore how increasing complexity is shaping partnerships, how labs and decentralized

en

00:22:21

MMF Rewind | Life After Transplant, Reimagined:...

Moving Medicine Forward ·

2026/05/27

In this MMF Rewind, we’re bringing back an important conversation with Lynda Lee Smith—one that shines a light on the ongoing challenges transplant families face and the critical role of research in improving outcomes.Lynda Lee Smith, CEO of Enduring Hearts, is featured on the Moving Medicine Forward Podcast to discuss the mission and impact of the nation’s only nonprofit dedicated to funding pediatric heart transplant research. In this conversation, Lynda addresses the challenges transplant

en

00:26:12

CTI’s Next Chapter: A Conversation with Jon Koch and...

Moving Medicine Forward ·

2026/05/19

In this episode, Jon Koch, CEO, and Brian Lawrence, CFO and President, share their perspective on what’s next for CTI as the organization enters a new phase of growth. They reflect on CTI’s legacy of partnership and execution while outlining how they plan to expand its impact across complex clinical trials.From scaling capabilities and investing in talent to strengthening operational discipline and embracing data driven decision-making, Jon and Brian offer an inside look at how leadership alignment

en

76 results

Similar Podcasts

The Deep Dive Lab: Unraveling Materials Science

Son Hoang

New Books in Political Science

New Books Network

Station 151

Pale Matter | Realm

Beyond the Divide

Koala Moon

StarTalk with Neil deGrasse Tyson

Neil deGrasse Tyson